Finance

Lists
Why is 524516 down 4,74%?
Dive Deeper
524516:BOM
Bacil Pharma Ltd
₹21,93
-4,74%
(-1,09) 1D
15 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524516...
Open
₹22,56
High
₹22,56
Low
₹21,92
Mkt. cap
314,76 m
Avg. vol.
49,98 k
Volume
5,71 k
P/E ratio
39,35
52-wk high
₹61,80
52-wk low
₹10,65
EPS
₹0,56
No. of employees
2
Open
₹22,56
High
₹22,56
Low
₹21,92
Mkt. cap
314,76 m
Avg. vol.
49,98 k
Volume
5,71 k
P/E ratio
39,35
52-wk high
₹61,80
52-wk low
₹10,65
EPS
₹0,56
No. of employees
2
News stories
From web sources and news partners
About Bacil Pharma Ltd
CEO-
Employees2
Founded1987
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
63,00 k
60,00 k
109,00 k
72,00 k
Operating expense
365,00 k
253,00 k
743,00 k
227,00 k
Total operating expenses
365,00 k
253,00 k
743,00 k
227,00 k
Operating income
-365,00 k
-253,00 k
-743,00 k
-227,00 k
Other non operating income
549,00 k
645,00 k
-1,22 m
891,00 k
EBT including unusual items
184,00 k
392,00 k
390,00 k
664,00 k
EBT excluding unusual items
184,00 k
392,00 k
390,00 k
664,00 k
Income tax expense
46,00 k
-
-7,95 m
825,00 k
Effective tax rate
25,00%
-
-2 037,95%
124,25%
Other operating expenses
302,00 k
193,00 k
634,00 k
155,00 k
Net income
138,00 k
392,00 k
8,34 m
-161,00 k
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
2,35 m
-
Interest expense
-
-
-
-
Net interest expenses
-
-
2,35 m
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-363,25 k
-251,25 k
-741,25 k
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme